Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018

Joel Beatty Maintained (VNDA) at Strong Buy with Increased Target to $31 on, Oct 16th, 2018

Joel Beatty of Citigroup, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Strong Buy with Increased Target from $27 to $31 on, Oct 16th, 2018.

Joel has made no other calls on VNDA in the last 4 months.



There are 2 other peers that have a rating on VNDA. Out of the 2 peers that are also analyzing VNDA, 1 agrees with Joel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Charles Duncan of "Cantor Fitzgerald" Initiated at Hold and Held Target at $26 on, Thursday, August 23rd, 2018


This is the rating of the analyst that currently disagrees with Joel


  • Derek Archila of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Friday, September 21st, 2018